For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $4.39 in the prior trading day, Vistagen Therapeutics Inc (NASDAQ: VTGN) closed at $4.36, down -0.68%. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 0.59 million shares were traded. VTGN stock price reached its highest trading level at $4.5 during the session, while it also had its lowest trading level at $4.3.
Ratios:
Our goal is to gain a better understanding of VTGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTGN now has a Market Capitalization of 172200176 and an Enterprise Value of 96890168. For the stock, the TTM Price-to-Sale (P/S) ratio is 246.01 while its Price-to-Book (P/B) ratio in mrq is 2.56. Its current Enterprise Value per Revenue stands at 134.383 whereas that against EBITDA is -1.484.
Stock Price History:
The Beta on a monthly basis for VTGN is 0.23, which has changed by 0.89224136 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, VTGN has reached a high of $5.14, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is 4.21%, while the 200-Day Moving Average is calculated to be 42.92%.
Shares Statistics:
The stock has traded on average 712.87K shares per day over the past 3-months and 1042040 shares per day over the last 10 days, according to various share statistics. A total of 38.89M shares are outstanding, with a floating share count of 33.66M. Insiders hold about 14.78% of the company’s shares, while institutions hold 44.98% stake in the company. Shares short for VTGN as of 1764288000 were 1274319 with a Short Ratio of 1.79, compared to 1761868800 on 1357492. Therefore, it implies a Short% of Shares Outstanding of 1274319 and a Short% of Float of 4.61.
Earnings Estimates
The company has 4.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.42.
Analysts are recommending an EPS of between -$1.43 and -$1.84 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.64, with 4.0 analysts recommending between -$1.6 and -$1.73.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for VTGN’s current fiscal year. The highest revenue estimate was $1.44M, while the lowest revenue estimate was $500k, resulting in an average revenue estimate of $891.8k. In the same quarter a year ago, actual revenue was $486k
